Quantum appoints national account manager

Pauline Carter brings 18 years’ experience to the role

Quantum Pharmaceutical, a UK-based pharmaceutical specials manufacturer, has appointed Pauline Carter as national account manager. Carter brings more than 18 years’ industry experience to the role.

Carter has previously been responsible for increasing retail sales and negotiating new sales opportunities for a number of international pharmacy companies including AAH Pharmaceuticals and Mylan. She has also worked as a prescribing technician for Central Cheshire Primary Care Group.

The company says Carter’s industry credentials and experience of working in both hospital and retail pharmacy will enable the firm to extend its partnerships with hospitals and dispensing doctors.

You may also like

Finance

Sanofi completes acquisition of Blueprint Medicines

Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation, adding to its portfolio a commercialised medicine and the expertise of a company specialising in systemic mastocytosis (SM) and other KIT-driven diseases
Finance

Evestia Clinical to merge with Atlantic Research Group

The merger delivers on Evestia Clinical’s strategy of targeted growth through the expansion of services, enhanced technology and broadened geographical reach
Research & Development

Amphista Therapeutics reaches research milestone and triggers a milestone payment from Merck

Collaboration focuses on the discovery of novel, non-CRBN/VHL, Targeted Glue degraders for oncology and immunology indications
Manufacturing

Gerresheimer reports H1 2025 growth driven by Bormioli Pharma acquisition

Cosmetics and oral liquids markets dampen organic revenue but outlook remains strong
Research & Development

Strategic investment by Bain Capital, Kohlberg and Mubadala fuels PCI Pharma Services’ expansion

This financial injection is expected to cement PCI’s position in the CDMO arena
Finance

Pila Pharma bags nearly £1.5m to aid obesity drug development

The ex-Novo Nordisk researcher-founded biotech will use the money to expand its obesity clinical pipeline
Research & Development

Ofichem Group to acquire drug formulation development specialist, Avivia

Ofichem will now be able to offer its clients a range of early-stage development services, from analytical method development to excipient characterisation
Subscribe now